STAG2 and melanoma: In a later work based on IHC of melanoma specimens, it was found that DUSP6 protein, as well as STAG2 and STAG3, two cohesin complex components, are decreased following treatment with BRAF or MEK (dabrafenib, trametinib, andvemurafenib) inhibitors.